7QD.F CLOVER HEALTH INV. CL.A
- Market cap
- EUR 2.36B
- P/E
- 440.0x
- P/B
- 6.49x
- ROE
- 21.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 7QD.F undervalued?
Graham numberThe Graham number of CLOVER HEALTH INV. CL.A cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
CLOVER HEALTH INV. CL.A fundamental analysis
No fundamental analysis for CLOVER HEALTH INV. CL.A yet.
CLOVER HEALTH INV. CL.A stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About CLOVER HEALTH INV. CL.A
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Full company profileCLOVER HEALTH INV. CL.A financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
CLOVER HEALTH INV. CL.A annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 1.47B | 1.10B | 1.26B | 1.37B | 1.92B | 3.00B |
| Gross Profit | -79.2M | 103M | 256M | 365M | 356M | 590M |
| Operating Income | -637M | -287M | -180M | -45.5M | -85.5M | 82.4M |
| EBITDA | - | -252M | -208M | -44.9M | -83.9M | 84.6M |
| Net Income | -588M | -340M | -213M | -43.0M | -85.5M | 82.4M |
| EPS | -1.25 | -0.71 | -0.44 | -0.09 | -0.16 | 0.15 |
| Balance Sheet | ||||||
| Total Assets | 951M | 809M | 571M | 581M | 541M | 754M |
| Total Liabilities | 411M | 452M | 284M | 240M | 232M | 363M |
| Shareholders' Equity | 535M | 357M | 286M | 341M | 309M | 391M |
| Cash & Short-term Investments | 300M | 104M | 116M | 195M | 78.3M | 268M |
| Cash Flow | ||||||
| Operating Cash Flow | -282M | -204M | -145M | 34.8M | -66.9M | 271M |
| Capital Expenditure | 723K | 4.47M | 584K | 1.56M | 2.04M | 3.25M |
| Free Cash Flow | -283M | -208M | -145M | 33.3M | -69.0M | 268M |
| Ratios | ||||||
| ROE | -109.8% | -95.1% | -74.5% | -12.6% | -27.7% | 21.1% |
| ROA | -61.8% | -42.0% | -37.4% | -7.4% | -15.8% | 10.9% |
| Net Profit Margin | -39.9% | -31.0% | -16.9% | -3.1% | -4.4% | 2.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
CLOVER HEALTH INV. CL.A dividends
CLOVER HEALTH INV. CL.A has not paid dividends in the last 5 fiscal years.
Who owns CLOVER HEALTH INV. CL.A
- Insiders 4.26%
- Institutions 35.06%
- Public & others 60.69%
- Shares outstanding 440M
- Free float 417M
CLOVER HEALTH INV. CL.A company profile
- Company name
- CLOVER HEALTH INV. CL.A
- Ticker
- 7QD.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 724
- Fiscal year end
- December
- Address
- 1209 Orange Street, Wilmington, DE, United States, 19801
- Phone
- 201 432 2133
- Website
- cloverhealth.com
About CLOVER HEALTH INV. CL.A
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
CLOVER HEALTH INV. CL.A management
10- Mr. Vivek GaripalliCo-Founder & Executive Chairman · born 1979
- Mr. Andrew ToyCo-Founder, CEO & Director · born 1979
- Ms. Jamie L. ReynosoChief Executive Officer of Medicare Advantage · born 1969
- Mr. Conrad WaiCEO of Counterpart Health · born 1981
- Ms. Wendy RicheyChief Compliance Officer
- Ms. Karen SoaresChief Legal Officer, General Counsel, Senior VP & Corporate Secretary · born 1978
- Ms. Rachel FishChief People Officer
- Dr. Kumar DharmarajanChief Medical Officer of Clover Assistant · born 1980
- Dr. Mark Spektor D.O., M.B.A.Chief Medical Officer · born 1971
- Mr. Aric SharpChief Executive Officer of Value Based Care · born 1973